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Abstract
Background: Children with chronic illnesses are known to have increased risks for emotional and behavioral
problems. In the present study, children and adolescent suffering from celiac disease (CD) were compared with
healthy controls to assess differences in the psychological profile.
Methods: A total of 100 well-treated and compliant CD patients (65 females/35 males; age mean ± SD: 10.38 ±
2.71) were compared to 100 normal controls (58 females/42 males; age mean ± SD: 11.47 ± 2.61). Emotional and
behavioral problems were assessed by the Child Behavior Checklist (CBCL), the Children’s Depression Inventory
(CDI) and the Multidimensional Anxiety Scale for Children (MASC).
Results: Subjects with CD self-reported an increased rate of anxiety and depression symptoms and showed higher
scores in “harm avoidance” and “somatic complaints”, in the CBCL parent-report questionnaire, as compared to
healthy control subjects. Furthermore, gender differences could be observed in the group of CD patients, with
males displaying significantly higher CBCL externalizing scores, in social, thought and attention problems, as
compared to female, who in turns showed more prominent internalizing symptoms such as depression.
Conclusions: The increased rate of emotional and behavioral problems in children and adolescent with CD
emphasizes the importance of an early detection of mental health problems in these children.
Background
Celiac disease (CD) is an autoimmune enteropathy char-
acterized by intolerance to dietary gluten. The clinical
spectrum of celiac disease is extremely wide, varying in
onset, duration and severity of the disease, and the com-
pliance to a gluten-free diet is also extremely variable.
Besides the classic form, which shows the typical gastro-
intestinal manifestations, there are also atypical and
asymptomatic (silent) forms of celiac disease [1-3].
Celiac disease can also be f o u n di na s s o c i a t i o nw i t h
other autoimmune diseases (i.e. diabetes, thyroiditis of
Hashimoto, psoriasis), as well as with extra-intestinal
complications such as neurologic and psychiatric distur-
bances, which may either follow or precede symptoms
and diagnosis of the celiac disease [4-6]. Several studies
have documented the occurrence of internalizing disor-
ders such as depression, anxiety, and psychoneurotic
symptoms in adults with celiac disease, before or after
the introduction of a gluten-free diet and food restric-
tion [7-11]. Children with celiac disease can also suffer
from neurological and psychological disorders, including
headaches, attention-deficit/hyperactivity disorder
(ADHD), learning and tic disorders, depression and
anxiety, mostly before any dietary treatment [12-15]. An
association between autism and CD has also been
reported, although a direct link still has to be deter-
mined [16,17]. Recently, another study suggested the
existence of a low prevalence of neurological and psy-
chiatric disorders such as febrile seizures, epilepsy, head-
ache, mental retardation, neuropathy, and bipolar
disorder in children with gluten sensitivity [18].
The pathogenesis processes responsible for the neuro-
logical complications in celiac disease still remain poorly
understood [19], even if several mechanisms have been
proposed. Indeed, some studies have hypothesized a role
for the deficit of folic acid, vitamin E, and biopterin,
documented in these patients, whereas other studies
have identified crossreacting antibodies, immune
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players [20,21]. Recently, additional factors have been
suggested, including brain perfusion abnormalities [22],
which have been observed in the superior and anterior
areas of the frontal cortex and anterior cingulated cortex
in patients with celiac disease [20]. An alteration of per-
fusion in the same brain areas has also been reported in
patients with neurological and psychiatric disorders,
including depression and anxiety, thus providing a pos-
sible explanation for the association between the two
conditions [23,24].
Since gluten-free or vitamin-supplemented diets were
introduced for the treatment of these patients, several
studies have tried to investigate the effects of these spe-
cific dietary regimens on the neurological and psycholo-
gical aspects associated with celiac disease, providing
somewhat conflicting results [25-27]. For instance, in
one study, the beginning of a standard gluten-free diet,
or a vitamin B-6-supplemented gluten-free diet was
shown to improve internalizing symptoms in adults [25].
In line with this, another study reported that ADHD-like
symptoms were markedly overrepresented among
untreated CD patients (age range: 3 to 57) and that a
gluten-free diet improved symptoms within a short per-
iod of time [26]. Finally, the institution of a gluten-free
diet in a group of children with CD was also shown to
improve neurological symptoms such as headaches in
77% of the cases [12]. Conversely, it has also been
described that depressive symptoms can arise after the
introduction of a gluten-free diet [27]. However, so far,
only a few reports have described the pattern of beha-
vioral and emotional characteristics in CD children after
the introduction of a gluten-free diet.
In the present study, we evaluated the emotional and
behavioral profiles in a sample of children suffering
from celiac disease undergoing a strict gluten-free regi-
men, to try to identify peculiar psychological features,
both as compared to healthy peers and within the CD
group itself according to gender.
Methods
Patients and controls
A total of 100 children (65 females/35 males, aged 7 to
18 years) suffering from celiac disease were included in
the study. Diagnosis of celiac disease was aided by the
following serologic assays: IgA and IgG anti-gliadin anti-
body (AGA), IgA-class EMA and IgA-class anti-tTG
antibodies in the serum of these patients. Antiendomy-
sium antibodies (EMA) are evaluated by indirect immu-
nofluorescence assay in umbilical cord substrate, as
previously described [28,29]. All subjects were hospita-
lized at the time of diagnosis, submitted to a strict glu-
ten-free diet and checked every six months. Self-
reported adherence to the gluten-free diet was good in
95% of patients, with only 5% reporting being on a fairly
strict gluten-free regimen. The histological analysis of
biopsy specimens obtained from the distal part of the
duodenum revealed the presence of a gluten sensitive
enteropathy, according to the ESPGHAN criteria [1].
A total of 100 age-matched control children (58
females/42 males) were randomly selected from a data-
base of healthy children attending a well-being pediatric
clinic for normal developmental check-up. Control sub-
jects were also tested for the presence of anti-gliadin
antibody, anti-endomysial antibody, and anti-tissue
transglutamine antibody. The socioeconomic status of
the families was determined using different indicators,
including parental educational level, parental occupa-
tional level and family’s availability of material resources.
Inclusion criteria for CD patients were the following:
- clinical and laboratory diagnosis of CD
- absence of mental retardation
- lack of relevant psychopathological disorders in the
family.
The present study was approved by the institutional
review board of ethics committee at the “Policlinico
Institute” of University of Catania, Catania, Italy. At the
time of enrollment in the study, mothers and adoles-
cents gave written consent and assent, respectively.
Assessment of behavioural and emotional problems
The Multidimensional Anxiety Scale for Children
(MASC), 39-item four point Likert-style self-report
scale, was used to measure anxiety symptoms: physical
symptoms, harm avoidance, social anxiety and separa-
tion anxiety were evaluated. Raw scores were converted
into standard T-scores, and T-score >65 indicated the
presence of anxiety symptoms. The MASC was also
completed by the children [30].
The Child Behaviour Checklist (CBCL), a 113-item
questionnaire, was completed by the parents of CD
patients. The CBCL is used to rate children behavior
and emotional problems, both globally and along the
two dimensions of internalizing symptoms (anxiety and
depression), and externalizing symptoms (aggression
and hyperactivity). Raw scores for each clinical factor
were transformed into T-scores based on published
norms. T-scores ≥ 70 were considered indicative of clin-
ical impairment [31,32].
The Children’s Depression Inventory (CDI), completed
by the child, was used to rate depression symptoms.
This scale consists of 27 items scored on a three-point
scale (0 absent, 1 moderate and 2 severe) indicating the
growing severity of symptoms. A 19-point cut-off indi-
cates the ideal threshold for discriminating children at
risk of depression from healthy children [33].
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assessed by evaluating the criteria outlined in the DSM-
IV-TR [34]. In the CD group, the neuropsychological
evaluation was conducted 6-9 months after the diagnos-
tic biopsy.
Data analysis
Statistical analyses were performed using the Statistical
Package for Social Sciences (SPSS 14.0 for Windows).
Both descriptive and inferential analyses were underta-
ken, including Chi square test, Student’s t-test and non-
parametric tests. To investigate gender differences
within the CD group the Chi-square test and the Fish-
er’s exact test were also performed. An alpha level of .05
was used for all statistical tests.
Results
Clinical characteristics
The present study included 200 children and adoles-
cents. Among them, 100 (35 males/65 females, age
mean ± SD: 10.38 ± 2.71) suffered from celiac disease
and 100 (42 males/58 females, age mean ± SD: 11.47 ±
2.61) were included in the normal control (NC) group.
The demographic and clinical characteristics of the sam-
ple are summarized in Table 1. The CD and NC groups
were similar for age and gender distribution, as well as
for the socioeconomic status of their families. Among
children with celiac disease, 25 suffered from somatic
complaints including headache (19 children out of 100),
stomachache (9/100) or musculoskeletal pains (2/100).
Furthermore, two children in the CD group could be
classified within the spectrum of autistic disorders,
according to DSM-IV-TR.
Emotional and behavioral profile
CD children showed significantly higher scores in the
two completed self-rating scales (MASC and CDI) as
compared to normal controls: 50.0 ± 8.3 vs. 42.9 ± 6.6
(p < 0.01) for total MASC, and 8.1 ± 5.7 vs. 5.6 ± 3.4 (p
< 0.01) for CDI scale, respectively; MASC subscales
“harm avoidance” and “separation panic” also revealed
higher scores for CD children (44.8 ± 9.3 vs. 41.9 ± 9.2;
p = 0.028 and 55.0 ± 10.7 vs. 48.7 ± 8.7; p < 0.01,
respectively, for the comparison with NC) (Table 2; Fig-
ure 1). Although, according to the established norms,
most of the patients had scores within the non-patholo-
gical range, a higher proportion of CD patients had
pathological MASC total scores (T-score > 65) as com-
pared to NC (48.6% vs. 12.8%; p < 0.05) (Figure 2).
The CBCL analysis, completed by the parents, failed
to show any significant differences in total, internalizing
and externalizing scores between the two groups; how-
ever, the subscale “somatic complaints” revealed higher
scores for CD patients than for NC (57.5 ± 7.6 vs. 54.6
± 6.6; p = 0.004) (Table 2)
The results of the neuropsychological tests were also
analyzed in relation to the elapsed time since diagnosis
of CD: an inverse correlation was observed with CDI
and MASC total scores (CDI: r = -0.26; P = 0.03;
M A S C :r=- 0 . 2 4 ;P=0 . 0 4 ) ,b u tn o tw i t hC B C Lt o t a l
and subscale scores (CBCL tot: r = -0.14; P = 0.25;
Table 1 Demographics and clinical characteristics of the
sample
Groups Celiac Subjects
(N = 100)
CTRL
(N = 100)
p
a
Males/females 35/65 42/58 NS
Age (mean ± SD) 10.38 ± 2.71 11.47 ± 2.61 NS
Age at onset (mean ± SD)
Male 3.51 ± 2.67 - -
Female 4.66 ± 4.39 - -
a NS indicates p > 0.05.
Table 2 Average psychological and behavioral scores in
celiac and control groups
Groups Celiac Subjects
(N = 100)
CTRL
(N = 100)
p
f
CBCL Total
a 51.2 ± 9.7 51.1 ± 9.2 NS
CBCL Int
b 51.4 ± 9.4 52.3 ± 8.4 NS
CBCL Ext
c 49.0 ± 8.9 51.8 ± 8.5 NS
CDI
d 8.1 ± 5.7 5.6 ± 3.4 <0.01
MASC
e 50.0 ± 8.3 42.9 ± 6.6 <0.01
a Parent Child Behavior Checklist Total Score (T-scores);
b Parent Child
Behavior Checklist Internalizing Score (T-scores);
c Parent Child Behavior
Checklist Externalizing Score (T-scores);
d Children’s Depression Inventory (raw
scores);
e Multidimensional Anxiety Scale for Children (T-scores);
f NS indicates
P > 0.05.
Figure 1 MASC profile in celiac (males and females) and
normal control subjects. CTRL = normal controls; PS = physical
symptoms; HA = harm avoidance; SA = social anxiety; SP =
separation anxiety; ADI= Anxiety Disorder Index; TOT = Total
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0.55).
Gender difference within CD group
The analysis of the psychological profiles according to
the gender revealed significant differences between
males and females within the CD group (Table 3). CD
males showed significantly higher scores for total CBCL
externalizing items (52.3 ± 8.2 vs. 47.9 ± 8.7; P = 0.016),
as well as for the CBCL sub-items “withdrawn” (56.3 ±
10.2 vs. 52.9 ± 5.1; p = 0.028), “social” (55.2 ± 6.9 vs.
52.5 ± 4.1; p = 0.016), “thought” ( 5 3 . 7±5 . 6v s .5 1 . 8±
3.6; p = 0.042), and “attention” problems (57.3 ± 7.0 vs.
52.3 ± 3.9; p < 0.01), as compared to CD females (Table
3; Figure 3). By contrast, CD females showed an
increased rate of anxiety and depression symptoms, as
indicated by significantly higher MASC Total (48.6 ± 8.6
vs. 45.5 ± 8.9; p = 0.013) and CDI (7.9 ± 5.5 vs. 5.6 ±
3.4; p < 0.01) scores (Figure 1).
Discussion
Understanding the association between the onset of the
illness, as well as the changes in dietary regimens, and
the psychological sequels in young patients suffering
from CD is a crucial aspect to try to improve the quality
of their daily life. In the present study, we focused our
attention on the emotional and behavioral profile, to try
to identify the psychological symptoms that most likely
could arise in this pathological condition. Previous
reports have outlined the prevalence of emotional and
disruptive behavioral disorders in CD children, which
were improved after the introduction of the gluten-free
diet [12-15]. Similarly, ADHD symptoms were also
shown to decrease significantly by six months of gluten-
free regimens [14,15]. Other studies documented the
presence of anxious-depressive symptoms in the pre-diet
stage of the disease with a decrease of anxiety symp-
toms, but not of symptoms related to depression, after
switching diets [8].
The results shown in this study are partially contradic-
tory with the ones reported in the literature. In our
cohort, CD children on a strict gluten-free diet showed
Figure 2 Percent of subjects with MASC scores in the
pathological range in control and celiac groups. CTRL = normal
controls; T-score > 65 was considered as cut-off for pathological
range
Table 3 Emotional and behavioral profile: gender
differences in the celiac group
Groups Celiac Females
(N = 65)
Celiac Males
(N = 35)
p
f
CBCL Total
a 49.4 ± 9.2 53.6 ± 11.7 NS
CBCL Int
b 50.3 ± 8.5 53.9 ± 10.9 NS
CBCL Ext
c 47.9 ± 8.7 52.3 ± 8.2 0.016
CBCL subitems:
Withdrawn 52.9 ± 5.1 56.3 ± 10.2 0.028
Somatic Complaint 57.0 ± 7.0 57.6 ± 7.6 NS
Anxious/Depressed 52.9 ± 4.8 55.2 ± 6.3 NS
Social Problems 52.5 ± 4.1 55.2 ± 6.9 0.016
Thought Problems 51.8 ± 3.6 53.7 ± 5.6 0.042
Attention Problems 52.3 ± 3.9 57.3 ± 7.0 < 0.01
Delinquent Behavior 52.7 ± 4.4 54.6 ± 5.4 NS
Aggressive Behavior 52.4 ± 4.5 54.5 ± 6.2 NS
MASC Total
d 48.6 ± 8.6 45.5 ± 8.9 0.013
CDI
e 7.9 ± 5.5 5.6 ± 3.4 <0.01
a Parent Child Behavior Checklist Total Score (T-scores);
b Parent Child
Behavior Checklist Internalizing Score (T-scores);
c Parent Child Behavior
Checklist Externalizing Score (T-scores);
d Multidimensional Anxiety Scale for
Children (T-scores);
e Children’s Depression Inventory (raw scores);
f NS
indicates P > 0.05.
Figure 3 CBCL profile in celiac group: gender difference.W=
Withdrawn; SC = Somatic Complaint; AD = Anxious/Depressed; SP
= Social Problems; TP = Thought Problems; AP = Attention
Problems; DB = Delinquent Behavior; AB = Aggressive Behavior
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7.41+/-4.08 years after diagnosis and initiation of diet, as
compared to healthy control individuals. Furthermore,
an increase in depressive and anxiety symptoms from
the time of CD diagnosis was also observed, even if no
further increases were documented advancing with age.
Moreover, most of CD patients still showed significantly
higher scores for anxiety, harm avoidance, separation
panic and somatic complaints, even after the introduc-
tion of dietary regimens [8,14,15]. Likewise, symptoms
of depression were significantly higher in CD children
as compared to normal controls, with 13.84% females
(vs. 8.57% males) exceeding the cut-off. Furthermore, as
investigated by CBCL, females with CD showed higher
scores for internalizing symptoms (i.e. anxiety) as com-
pared to males, whereas CD males showed significantly
higher externalizing scores (including withdrawn, social,
thought and attention problems). These findings may
suggest that females and males with CD perceive the
burden of their disease in a different manner and are in
line with the results of a previous study reporting a
poorer psychological general well being in female than
male [11]. The introduction of a gluten free diet results
in a radical change in eating habits and lifestyle of CD
children, and it can be hard to accept and stressful to
follow. This contributes to induce in most patients a
high level of anxiety, which may show in a different way
according to the gender susceptibility, resulting in
depression in females and aggression and irritability in
males [4]. Acceptance of the gluten-free diet is also
dependent on the age, as the adaptation to the regimen
is particularly problematic for adolescents between 12 to
17 years old, a time in life when the interactions with
peers and adults become more difficult. In this context,
a strict food regimen can be considered of negative
influence on the social life. In line with this, previous
studies showed that children and adolescents suffering
from other chronic conditions such as migraine, asthma
and fibromyalgia, were more anxious and depressed as
compared to their healthy peers [35-37]. Taken together,
all these reports indicate that the impact of a chronic
condition during childhood and adolescence may be dif-
ficult to manage, thus representing a risk factor for psy-
chiatric disorders in subjects with psychologic
vulnerability. In these delicate conditions the family in a
first place, and the social environment in a second,
become of crucial importance for the acceptance of the
illness: parents should encourage their children not to
hide their condition, thus contributing to increase their
self-esteem [38,39].
Besides the significant results, the present study shows
important limitations and it should be viewed in the
context of the following considerations. First, consider-
ing that the subjects included in the study were entirely
derived from a single university clinic, this sample can-
not be assumed as indicative of non-academic setting.
Indeed, the sample was clinically referred and not
intended to be representative of children with CD in the
population. Second, symptoms scores were derived from
assessment scales filled out by the parents and self-
report questionnaires completed by the children them-
selves, and a formal diagnosis of psychiatric disorders
was not performed (although these rating scales have
been shown to be valid instruments to identify children
with psychiatric symptoms). Third, even though the
social and cognitive relational skills of these patients
were evaluated by professional child neuropsychiatrists,
however, a complete cognitive evaluation with norma-
tive scale was not assessed.
Conclusion
Besides the limitations outlined above, the results pre-
sented here, showing a higher incidence of psychological
problems in children suffering from celiac disease under
strict food regimens, suggest that these patients may
need a psychological support, in order to improve the
acceptance of the gluten-free diet, thus limiting the lack
of compliance to treatment and the related disease com-
plications. Ideally, this type of psychological intervention
should also involve parents and school teachers, which
may play an essential role in such diseases in order to
promote a good social adaptation [40]. Our previous
experience has shown that such a cognitive-behavioral
family therapy might be an effective tool for improving
emotional and behavioral disorders in children with a
chronic and painful disease such as beta-thalassaemia
major [41]. Therefore, cognitive behavioral family ther-
a p ym a ya l s ob eau s e f u lt o o lt og i v es u p p o r tt oC D
children and their families.
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